Diabetes, Vol 38, Issue 9 1133-1141, Copyright © 1989 by American Diabetes Association

ARTICLES

Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen

S Baekkeskov, G Warnock, M Christie, RV Rajotte, PM Larsen and S Fey
Hagedorn Research Laboratory, Gentofte, Denmark.

Antibodies in serums from newly diagnosed insulin-dependent (type I) diabetes mellitus (IDDM) patients and individuals experiencing early phases of beta-cell destruction specifically immunoprecipitate a minor pancreatic islet cell membrane protein of 64,000 Mr (64K). In this report, we demonstrate the use of two-dimensional (2-D) gel electrophoresis to unambiguously identify the 64K antigen. By nonequilibrium pH-gradient gel electrophoresis in the first dimension and sodium dodecyl sulphate-polyacrylamide gel electrophoresis in the second dimension, the 64K protein separates into two components, designated alpha and beta, that differ in size but display identical charge heterogeneity. The high resolution of the 2-D method efficiently separates the 64K components from background proteins in immunoprecipitates from crude detergent lysates of islets. The background proteins were identified as major cellular proteins carried nonspecifically through the immunoprecipitation procedure. The high affinity and specificity of the 64K autoantibodies were demonstrated by the exclusive and greater than 1000-fold purification of this minor protein by immunoprecipitation with IDDM serums. The 2-D analyses did not reveal additional proteins specifically immunoprecipitated by IDDM serums, suggesting that the 64K protein is the only protein antigen specifically and consistently recognized by IDDM autoantibodies in the relatively stringent conditions of immunoprecipitation. Moreover, the 2-D analyses demonstrate that purification of membrane protein fractions from both human and rat islets before the immunoprecipitation efficiently removes background proteins and substantially increases the specificity of 64K autoantibody measurements by traditional methods.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. M. Gillespie Type 1 diabetes: pathogenesis and prevention. Can. Med. Assoc. J., July 18, 2006; 175(2): 165 - 170. [Abstract] [Full Text] [PDF]

				J. Malmstrom, H. Lindberg, C. Lindberg, C. Bratt, E. Wieslander, E.-L. Delander, B. Sarnstrand, J. S. Burns, P. Mose-Larsen, S. Fey, et al. Transforming Growth Factor-{beta}1 Specifically Induce Proteins Involved in the Myofibroblast Contractile Apparatus Mol. Cell. Proteomics, May 1, 2004; 3(5): 466 - 477. [Abstract] [Full Text] [PDF]

				Y. Shi, J. Kanaani, V. Menard-Rose, Y. H. Ma, P.-Y. Chang, D. Hanahan, A. Tobin, G. Grodsky, and S. Baekkeskov Increased expression of GAD65 and GABA in pancreatic beta -cells impairs first-phase insulin secretion Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E684 - E694. [Abstract] [Full Text] [PDF]

				L. Geng, M. Solimena, R. A. Flavell, R. S. Sherwin, and A. C. Hayday Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease PNAS, August 18, 1998; 95(17): 10055 - 10060. [Abstract] [Full Text] [PDF]

				M. Namchuk, L. Lindsay, C. W. Turck, J. Kanaani, and S. Baekkeskov Phosphorylation of Serine Residues 3,6,10,and 13Distinguishes Membrane Anchored from Soluble Glutamic Acid Decarboxylase 65and Is Restricted to Glutamic Acid Decarboxylase 65alpha J. Biol. Chem., January 17, 1997; 272(3): 1548 - 1557. [Abstract] [Full Text] [PDF]